利润表
AIM IMMUNOTECH INC.
AIM
业绩概览
点击表格中任意一行将其添加到图表
单位：百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
营业收入
|
0.09 | 0.17 | 0.20 | 0.14 | 0.14 | 0.16 | 0.14 | 0.37 | 0.44 | 0.09 | 0.13 | 0.20 | 0.15 | 0.21 | 0.16 |
|
营业成本
|
- | - | - | - | - | - | - | - | - | - | - | 1.25 | 1.23 | 1.99 | 1.04 |
|
毛利润
|
0.09 | 0.17 | 0.20 | 0.14 | 0.14 | 0.16 | 0.14 | 0.37 | 0.44 | 0.09 | 0.13 | -1.05 | -1.08 | -1.78 | -0.88 |
|
营业费用
|
11.62 | 19.91 | 32.08 | 20.06 | 16.34 | 14.37 | 11.69 | 10.98 | 10.67 | 12.79 | 15.19 | 18.05 | 16.08 | 18.56 | 13.41 |
|
研发费用
|
3.92 | 6.20 | 10.94 | 6.99 | 7.67 | 5.72 | 4.65 | 4.78 | 4.10 | 5.11 | 8.04 | 8.99 | 8.36 | 9.51 | 6.72 |
|
销售、一般及行政费用
|
7.70 | 13.71 | 21.14 | 13.07 | 8.67 | 8.65 | 7.04 | 6.20 | 6.57 | 7.68 | 7.15 | 9.06 | 7.72 | 9.06 | 6.69 |
|
其他营业费用
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
营业利润
|
-11.54 | -19.74 | -31.87 | -19.92 | -16.21 | -14.21 | -11.55 | -10.61 | -10.23 | -12.70 | -15.05 | -19.10 | -17.17 | -20.34 | -14.30 |
|
营业外收入
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
利息收入
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
利息支出
|
0.81 | 0.59 | - | - | 0.07 | 0.67 | 0.24 | 0.20 | - | - | 0.00 | - | - | - | - |
|
其他营业外收入/支出
|
3.18 | 5.19 | 1.07 | 0.63 | - | - | - | - | - | - | - | - | 0.78 | 1.57 | - |
|
税前利润
|
-13.96 | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
所得税费用
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
少数股东损益
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
净利润
|
-13.96 | -17.32 | -28.96 | -19.45 | -19.13 | -14.40 | -9.53 | -9.81 | -8.26 | -7.50 | -15.23 | -17.45 | -16.23 | -17.35 | -9.02 |
补充资料
每股数据、派生项目及其他——不属于利润表
除特别注明外，单位均为百万美元
| 指标 | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY | Dec 31, 2016 2016 FY | Dec 31, 2015 2015 FY | Dec 31, 2014 2014 FY | Dec 31, 2013 2013 FY | Dec 31, 2012 2012 FY | Dec 31, 2011 2011 FY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
折旧与摊销
|
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
EBITDA
|
-11.54 | -19.74 | -31.87 | -19.92 | -16.21 | -14.21 | -11.55 | -10.61 | -10.23 | -12.70 | -15.05 | -19.10 | -17.17 | -20.34 | -14.30 |
|
基本每股收益
|
-8.62 | -0.31 | -0.60 | -0.40 | - | - | - | 0.02 | - | - | - | - | - | - | - |
|
稀释每股收益
|
-8.62 | -0.31 | -0.60 | - | - | - | - | - | - | - | - | - | - | - | - |
|
加权平均股数
|
1.62 | 56.02 | - | - | - | - | - | - | - | - | - | - | - | - | - |
|
稀释加权平均股数
|
1.62 | 56.02 | 48.59 | - | - | - | - | - | - | - | - | - | - | - | - |
|
综合收益
|
- | -17.32 | -28.96 | -19.45 | 0.05 | -0.05 | -9.53 | -0.01 | 0.02 | 0.09 | 0.06 | - | - | - | - |